Microdosed lithium has been investigated in preclinical and observational research for potential neuroprotective and cellular effects, particularly in brain tissue.
Some studies have explored associations between low environmental lithium exposure and markers of brain health, as well as hypotheses linking lithium signaling pathways to aging-related processes. However, these findings are not conclusive, and there is currently no FDA-approved indication for lithium as an anti-aging supplement or for the prevention of Alzheimer’s disease or other neurodegenerative conditions.
As a result, the use of microdosed lithium in this context remains experimental, and evidence in humans is still limited and not sufficient to support clinical recommendations for longevity or disease prevention.
Lithium and kidney function
Some concerns have been raised about the effects of lithium on kidney function, largely based on data from long-term clinical use. In psychiatric medicine, lithium is an FDA-approved treatment for conditions such as bipolar disorder, and it is well established that prolonged exposure at therapeutic doses can, in some patients, be associated with kidney-related side effects. These may include reduced kidney concentrating ability and, in some cases, fluid balance disturbances such as nephrogenic diabetes insipidus. For this reason, regular monitoring of renal function is standard practice in patients receiving lithium therapy.
Importantly, these effects are observed at therapeutic doses, which are substantially higher than so-called microdosed or trace lithium exposure. Clinical lithium treatment typically involves doses such as ~1,200 mg of lithium carbonate per day or more (sometimes exceeding 2,000 mg per day), corresponding to roughly ~120 mg or more of elemental lithium per day.
By contrast, microdosed lithium is commonly defined as approximately 0.3 to 1 mg of elemental lithium per day—at least ~100-fold lower than pharmaceutical dosing ranges. The amount used in NOVOS Core (1 mg of elemental lithium per day) falls within this low-dose range.
At these trace exposure levels, there is currently no established evidence showing the same kidney-related adverse effects observed with therapeutic lithium treatment. However, long-term safety data specifically for microdosed lithium remain limited.
Potential effects of low-dose lithium on kidney health
Beyond concerns related to high-dose pharmaceutical use, some research has explored whether low-dose or trace lithium exposure may have biological effects that are distinct from therapeutic dosing.
Experimental and preclinical studies suggest that lithium, at low concentrations, may influence cellular pathways involved in stress resistance and tissue maintenance. These include signaling mechanisms such as Nrf2 activation and neurotrophic factors like brain-derived neurotrophic factor (BDNF), which are also relevant in kidney cell biology. In animal and cellular models, such pathways have been associated with protection against oxidative stress and injury in renal tissue, suggesting a possible protective role under certain conditions.
Some observational ecological studies have also reported associations between naturally occurring lithium levels in drinking water and various health outcomes across populations. However, these findings are correlational and do not establish causation, and they should be interpreted cautiously given the potential for confounding factors.
Preclinical nephrology research has further investigated lithium’s role in renal aging and cellular repair mechanisms. As noted by Dr. Rujun Gong (University of Toledo College of Medicine), lithium has been proposed as a potential modulator of kidney aging processes, although this remains an emerging and not yet clinically established area of research.
Overall, while there is scientific interest in possible protective mechanisms of low-dose lithium at the cellular level, current evidence is preliminary. Clear clinical confirmation of kidney-protective effects in humans at microdoses has not yet been established.
Learn more about microdosed lithium and longevity here.
